SMI Expanded

SMI Expanded handeln
1.849,13 PKT -16,39 PKT -0,88 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0019399861


Analysen zu SMI Expanded-Werten

Datum Rating Analyst
13.09.12 UBS buy Nomura
13.09.12 Novartis reduce Vontobel Research
13.09.12 Holcim hold Vontobel Research
13.09.12 Swiss Prime Site hold Vontobel Research
13.09.12 ABB (Asea Brown Boveri) buy Vontobel Research
13.09.12 Swiss Prime Site buy Sarasin Research
12.09.12 Novartis neutral J.P. Morgan Cazenove
11.09.12 Givaudan outperform Exane-BNP Paribas SA
11.09.12 Novartis underperform Banc of America Securities-Merrill Lynch
11.09.12 Novartis outperform Sanford C. Bernstein and Co., Inc.
11.09.12 Roche outperform Sanford C. Bernstein and Co., Inc.
10.09.12 Swisscom hold Deutsche Bank AG
10.09.12 Nestlé buy Sarasin Research
10.09.12 Roche buy Banc of America Securities-Merrill Lynch
10.09.12 Nestlé kaufen Norddeutsche Landesbank (Nord/LB)
10.09.12 Geberit hold Vontobel Research
10.09.12 Swisscom hold Vontobel Research
10.09.12 Swiss Re buy Vontobel Research
07.09.12 Avolta (ex Dufry) buy Deutsche Bank AG
07.09.12 Roche outperform Exane-BNP Paribas SA
07.09.12 Holcim outperform Exane-BNP Paribas SA
07.09.12 Novartis neutral J.P. Morgan Cazenove
06.09.12 Holcim neutral J.P. Morgan Cazenove
06.09.12 Richemont neutral J.P. Morgan Cazenove
06.09.12 Swiss Re sell Goldman Sachs Group Inc.
06.09.12 Roche overweight J.P. Morgan Cazenove
06.09.12 Novartis neutral Exane-BNP Paribas SA
06.09.12 ABB (Asea Brown Boveri) buy UBS AG
06.09.12 UBS underperform Cheuvreux SA
06.09.12 Holcim outperform Exane-BNP Paribas SA
06.09.12 Holcim outperform Cheuvreux SA
06.09.12 Holcim hold ING
06.09.12 Roche buy Sarasin Research
05.09.12 Swatch (I) outperform Credit Suisse Group
05.09.12 UBS overweight J.P. Morgan Cazenove
05.09.12 UBS overweight J.P. Morgan Cazenove
05.09.12 Partners Group hold Vontobel Research
05.09.12 Holcim hold Vontobel Research
05.09.12 Novartis reduce Vontobel Research
05.09.12 Swiss Re buy Vontobel Research